All results
66 results for stronger study
-
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid
This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)
The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
DOTS (20-0002)
This is a Phase 2b clinical study, multicenter, randomized, open-label, assessor-blinded, superiority study. The study will compare dalbavancin to standard of…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Vasomune AV001-004
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Ne
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with…
- Ages
- N/A - 21 Years
- Sexes
- All
-
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adol
This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical [haplo]) versus matched unrelated…
- Ages
- 6 Months - 21 Years
- Sexes
- All
-
TREAT-MS
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has…
- Ages
- 18 Years - 60 Years
- Sexes
- All
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization…
- Ages
- 35 Years - 100 Years
- Sexes
- All
-
OCEANIC
Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots travelling through the…
- Ages
- 18 Years - N/A
- Sexes
- All